Other prevention strategies involve chemoprevention with selective estrogen receptor modulators such as tamoxifen or raloxifene or an aromatase inhibitor such as exemestane, and breast cancer screening with mammography and/or MRI [109,110]. Here, CYP19A1 is linked to breast cancer.